Teva agrees to pay $450 million to settle recall allegations, US Department of Justice says.

WASHINGTON (Reuters) – New Jersey-based drugmaker Teva has agreed to pay $450 million to settle allegations that it violated an anti-kickback statute and the False Claims Act, the U.S. Justice Department said on Thursday in a statement.

“Kickbacks designed to induce referrals or purchases of health care goods or services distort physician and patient decision making, impede competition, and circumvent controls put in place to protect federal health care programs,” said Senior Assistant Attorney General Brian M. Boynton, Head of Department. the civil section of the department.